The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 05, 2022
Filed:
Oct. 08, 2020
Applicant:
Ovid Therapeutics Inc., New York, NY (US);
Inventor:
Matthew During, Weston, CT (US);
Assignee:
Ovid Therapeutics Inc., New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61P 3/10 (2006.01); A61K 31/155 (2006.01); A61K 31/4985 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/155 (2013.01); A61K 31/4985 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2018.01);
Abstract
Methods and compositions for treating a metabolic disease include administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with a metabolic disease. In embodiments, administering gaboxadol or a pharmaceutically acceptable salt thereof to a patient diagnosed with a metabolic disease is effective to lower one or more of HbA1c level, fasting plasma glucose level, 2-hour oral glucose tolerance test (OGTT) result level, and random plasma glucose level. Gaboxadol or a pharmaceutically acceptable salt thereof may optionally be administered in combination with a hypoglycemic agent.